Nuclear Medicine

The Nuclear Medicine group was established in early 2021 due to the support of the Sêr Cymru programme, and supports Welsh ambitions for a medical radionuclide production facility in the region. The production facility would provide radionuclides for use in both diagnostic and therapeutic treatments in nuclear medicine, leading to better patient outcomes across the nation and beyond.

The research is a mixture of modelling and experimental, focusing on:

1. Radionuclide production in a reactor or accelerator environment, including the development of target materials or optimising irradiation flux.

2. Radionuclide extraction and purification from irradiated targets.

3. Development of carriers for novel radionuclides like Auger emitters.